2.46MMarket Cap-69P/E (TTM)
0.6680High0.6680Low97.58KVolume0.6680Open0.6321Pre Close65.19KTurnover2.66%Turnover RatioLossP/E (Static)3.69MShares12.000052wk High0.43P/B2.45MFloat Cap0.630052wk Low--Dividend TTM3.67MShs Float40500.0000Historical High--Div YieldTTM0.00%Amplitude0.6300Historical Low0.6680Avg Price1Lot Size
Quoin Pharmaceuticals Stock Forum
got to hold a dollar
Watch for shorts to cover shares today or tomorrow before ER
🚨 PUBLIC OFFERING 🚨
ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced the pricing of its "reasonable best efforts" public offering of 4,062,500 ordinary shares represented by 4,062,500 American Depositary Shares (or pre-funded warrants in lieu thereof), Series D warrants to purchase an aggregate of up to 4,06...
Earnings tomorrow
let's hope that's the catalyst needed to get this back over 4
🚨 WATCHING 🚨
FDA approval and the price tanks
Medical Company Granted FDA Clearance For Netherton Syndrome Clinical Trials
In a significant development that could potentially alter the trajectory of Netherton Syndrome treatment, Quoin Pharmaceuticals (NASDAQ: QNRX) has received clearance from the U.S. Food and Drug Administration (FDA) to include teenage subjects in their ongoing clinical studies. This decision is expected to broaden the ...
back to 5 please
No comment yet